GFAP and cryohydrocytosis: The α-SMA is a well-known and reliable mesenchymal marker of HSCs activation.8,18 Our observation of strong association of GFAP with the gold standard immunohistochemical marker, α-SMA, suggests that GFAP could be a useful indicator of early HSCs activation in CHC patients.